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What does each of the following have in common: Ebola, Marburg, Swine Flu, 
Spanish Flu and Avian flu? They are all diseases named after a location or an 
animal host.
In the past, this had been the norm: scientists rushed to name a new disease using 
the place where it was first identified. 
Marburg haemorrhagic fever was named after the City of Marburg in Germany in 
the 1960s. Swine flu and Avian flu were named after the animals thought to have 
hosted these infections. The origins of Spanish Flu are debated but it was ascribed 
to neutral Spain in 1918 by World War 1 censors in order to maintain morale 
among allied soldiers.
The idea of naming diseases after their locations started 
getting bad reviews in 1976 during the naming of the 
Ebola virus. According to an article on the etymology 
of Ebola virus: 
“When the international commission considered 
the name “Yambuku virus,” Karl Johnson and Joel 
Breman noted that naming the Lassa virus after the 
Nigerian village where it was discovered brought 
stigma to the community. Johnson suggested naming 
the virus after a nearby river, and the rest of the 
commission agreed”. [1]
It is clear the scientific community settled for Ebola 
to avoid leaving an indelible mark of horror on the 
village of Yambuku, and so avoid it being forever 
associated with a deadly disease.
It was the norm for the virus causative agent and 
the resulting disease to have different names. The 
World Health Organization’s (WHO) International 
Classification of Disease (ICD) names the diseases 
and the International Committee on Taxonomy of 
Viruses (ICTV) names the virus.
In 2003, a new coronavirus emerged in Yunnan, China. The WHO moved very 
quickly to give it a name before a nickname, given by the media, stuck. In order 
not to name it after the country (Chinese Virus) or the city (Yunnan Virus), 
the scientific group at WHO convened to name the virus. They wanted a name 
that included the causative agent or the clinical condition, and an acronym that 
is easy to use like HIV and AIDS. The WHO settled for SARS - Severe acute 
respiratory syndrome as the disease and the ICTV named the virus as the severe 
acute respiratory syndrome coronavirus (SARS-CoV).
In order to make it official, WHO developed best practices for naming new 
human infectious diseases in 2015.[2, 3] In consultation and collaboration with 
the World Organisation for Animal Health (OIE) and the Food and Agriculture 
Organization of the United Nations (FAO), WHO developed the best practices 
with the aim:
“to minimize unnecessary negative impact of disease names on trade, travel, 
tourism or animal welfare, and avoid causing offence to any cultural, social, 
national, regional, professional or ethnic groups”.
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This illustration, created at the Centers for Disease Control and 
Prevention (CDC), reveals ultrastructural morphology exhibited by 
coronaviruses (credit: CDC)
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In short, the scientific community cannot henceforth 
name a new disease based on the old practice of location, 
etc. It was a game changer.
When the new coronavirus started in China in December 
2019, the media started labelling it the “Wuhan” or 
“Chinese” virus, according to the location where it started. 
There were also media references to a 1981 apocalyptic 
novel by Dean Koontz, The Eyes of Darkness, which 
mentioned a killer virus called “Wuhan-400”. However, 
Koontz did not predict the corona virus outbreak in his 
novel.[4]
Because of its similarities to the SARS-CoV mentioned 
earlier, the ICTV named the virus severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2). Based on its 
guidance on best practices, WHO’s ICD settled on 
naming the new emerging disease ‘COVID-19’ – standing 
for COrona VIrus Disease of the year 2019. This was a 
response to avoid a stigmatizing name for the virus being 
used by the media.
SPECIAL ISSUE
Everyone should use the new name for this coronavirus 
disease in order not to stigmatize certain communities. 
Xenophobic attacks against Chinese or Chinese-looking 
citizens have aggravated the situation.
Calling it what it is can save lives.
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This special issue on COVID-19  has been produced by the SSMJ editorial team and SSMJ supporters 
inside and outside South Sudan. We  have put together an issue that deals entirely with the 
COVID-19 pandemic, drawing on reputable sources including WHO, UNICEF and CDC. 
COVID-19 is a new disease and new insights into the disease are being learnt every day. We 
continue to identify new symptoms and signs and management plans are evolving as our 
experience grows. People react differently to the disease. Most who develop serious problems 
and who succumb tend to be elderly or have underlying health conditions. We have  selected the 
information that provides reliable guidance according to current knowledge. Apologies if any links 
do not work in the future.
We hope this information will be useful to those dealing with the pandemic in South Sudan, and 
add to that provided by the government and other sources. These papers are just a start to the 
coverage of COVID-19 that SSMJ will be providing in future issues and on our website. 
We welcome contributions and suggestions from our readers, and we thank all the authors and 
reviewers who helped us to produce this special issue in a very short time.
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